Prelude Therapeutics reported for 202116.03.2022 at 14:38Сергей НовиковNews editorpress@blackterminal.comPrelude Therapeutics' GAAP loss for 2021 was $111.694 million, up 96.2% from $56.929 million the previous year. Prelude TherapeuticsPRLD5.37 USD-3.94%ReviewSource: investors.preludetx.com
